Floatz logo

Esomeprazole

Bariatric Surgery

Hospital dos LusíadasSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Bariatric Surgery cohort.

Asset / SponsorPhaseRating
PROPOFOL
Hospital dos Lusíadas
Phase 4BB
RAMIFENTANYL
Siirt Training and Research Hospital
Phase 4B
CIS-DIAMMINEDICHLOROPLATINUM II
University College Dublin
N/AD
Bms-907351
Universitaire Ziekenhuizen KU Leuven
D
Cefazolin
Hospital dos Lusíadas
N/AD

View all 21 →

Same molecule, other indications

Esomeprazole is also rated in:

gastrointestinal stromal tumorDormant
BB
Indicative ·
69 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →
morbid obesityDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →